Drug interaction

Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7.

Glycyrrhetinic Acid Exhibits Strong Inhibitory Effects Towards UDP-Glucuronosyltransferase (UGT) 1A3 and 2B7.

Filed under: Drug and Alcohol Rehabilitation

Phytother Res. 2012 Nov 12;
Huang YP, Cao YF, Fang ZZ, Zhang YY, Hu CM, Sun XY, Yu ZW, Zhu X,… Continue reading →

Drug and Alcohol Rehabilitation: New Drug Development for Cognitive Enhancement in Mental Health: Challenges and Opportunities.

New drug development for cognitive enhancement in mental health: challenges and opportunities.

Filed under: Drug and Alcohol Rehabilitation

Neuropharmacology. 2013 Jan; 64: 2-7
Insel T, Krystal J, Ehlers M

HubMed – drug

 

Evaluating and managing patients with thyrotoxicosis.… Continue reading →

Malcolm Bowden – Is Faith a Remedy for Depression?


 

Malcolm Bowden – Is faith a remedy for depression? – Malcolm Bowden is a Christian who believes that depression is not a real mental illness, but a manifestation of the cardinal sin of pride. Malcolm believes that true Christians… Continue reading →

Depression Treatment: Treating Depression Within the HIV “Medical Home”: A Guided Algorithm for Antidepressant Management by HIV Clinicians.

Treating Depression Within the HIV “Medical Home”: A Guided Algorithm for Antidepressant Management by HIV Clinicians.

Filed under: Depression Treatment

AIDS Patient Care STDS. 2012 Nov; 26(11): 647-54
Adams JL, Gaynes BN, McGuinness T, Modi R, Willig J, Pence… Continue reading →

Fexinidazole: A Potential New Drug Candidate for Chagas Disease.

Fexinidazole: a potential new drug candidate for chagas disease.

Filed under: Drug and Alcohol Rehabilitation

PLoS Negl Trop Dis. 2012 Nov; 6(11): e1870
Bahia MT, de Andrade IM, Martins TA, do Nascimento AF, Diniz Lde F, Caldas IS, Talvani… Continue reading →

Drug and Alcohol Rehabilitation: A Randomized Phase II Trial of Vismodegib Versus Placebo With FOLFOX or FOLFIRI and Bevacizumab in Patients With Previously Untreated Metastatic Colorectal Cancer.

A Randomized Phase II Trial of Vismodegib Versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer.

Filed under: Drug and Alcohol Rehabilitation

Clin Cancer Res. 2012 Oct 18;
Berlin JD, Bendell JC,… Continue reading →

Unexpected Neuronal Protection of SU5416 Against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase.

Unexpected Neuronal Protection of SU5416 against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2012; 7(9): e46253
Cui W, Zhang Z, Li W, Mak S, Hu S, Zhang H, Yuan… Continue reading →

Drug and Alcohol Rehabilitation: The Laboratory and the New Oral Anticoagulants.

The Laboratory and the New Oral Anticoagulants.

Filed under: Drug and Alcohol Rehabilitation

Clin Chem. 2012 Oct 5;
Tripodi A

BACKGROUND:The new oral anticoagulants (NOAs) dabigatran, rivaroxaban, and apixaban have proved effective and safe when used in clinical trials,… Continue reading →

BIOMARKERS of OPERATIONAL TOLERANCE in SOLID ORGAN TRANSPLANTATION.

BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION.

Filed under: Drug and Alcohol Rehabilitation

Expert Opin Med Diagn. 2012 Jul; 6(4): 281-293
Heidt S, Wood KJ

INTRODUCTION: Long-term immunosuppressive therapy represents a huge burden on transplant recipients, but currently… Continue reading →

Rehab Centers: The Western Model of Integrative Oncology – the Contribution of Chinese Medicine.

The Western model of integrative oncology – the contribution of Chinese medicine.

Filed under: Rehab Centers

Chin J Integr Med. 2012 Sep; 18(9): 643-51
Dobos GJ, Kirschbaum B, Choi KE

Western integrative oncology (IO) combines conventional mainstream medicine with… Continue reading →